FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...